Research-grade specs Sequence length: 39 amino acids Class: Triple GLP-1 / GIP / glucagon agonist Half-life: ~6 days (published literature) Available sizes: 10 MG, 15 MG, 20 MG, 40 MG Pharmaceutical status: Clinical development (TRIUMPH trials) Studied applications Triple-agonist mechanism research (vs single and dual agonists) Receptor-binding and metabolic-pathway studies Glucagon-receptor signaling research Comparative analysis with dual and single receptor agonist research compounds Quality & trust 99% HPLC purity, third-party tested Mass spectrometry identity confirmation LAL endotoxin testing on every batch Batch-specific Certificate of Analysis included cGMP manufactured in Dallas, Texas (USA) USA same-day shipping (orders before 2pm CT M-F) Free domestic shipping on orders over $200 Storage & handling Store lyophilized vials refrigerated at 28C, protected from light and heat Reconstitute with bacteriostatic water
Traber, M.G., 2024a
Patients with family history of these more common thyroid cancers are not automatically excluded from GLP-1 therapy based on this specific contraindication
New or worsening reflux symptoms that don't respond to simple measures should be discussed, as GLP-1 medications are not recommended in severe gastrointestinal disease
Inject the Medication : Slowly press the plunger to inject the medication
3 A widely used non-radioactive alternative is the C breath test , in which a stable-isotope-labeled substrate (often octanoate or spirulina) is metabolized after it passes into the small intestine, so the rate of labeled CO appearance in the breath reports on emptying